Your session is about to expire
← Back to Search
Tamsulosin for Urinary Retention
Study Summary
This trial will test whether the drug Tamsulosin can reduce the duration of acute urinary retention following pelvic reconstructive surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had issues with not being able to fully empty my bladder before surgery.I have severe memory loss that affects my daily life.I have end-stage kidney or liver disease.I have not had severe heart failure or a major heart event in the last 6 months.I have trouble urinating after surgery.I am currently taking medication for high blood pressure.I can swallow pills.I am 18 years old or older.I am allergic to Tamsulosin or sulfa drugs.
- Group 1: Placebo
- Group 2: Tamsulosin
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What precautionary measures should be taken when utilizing Tamsulosin?
"The safety of Tamsulosin was given a rating of 2 on the scale since this Phase 2 trial has data that attests to its security, but there is an absence of evidence for effectiveness."
Is recruitment still open for participation in this medical experiment?
"According to the particulars available on clinicaltrials.gov, this medical trial is actively searching for suitable volunteers. It was initially posted in November 2021 and recently amended in 2022."
What clinical applications is Tamsulosin typically used for?
"Tamsulosin has been identified as a viable treatment for bladder outlet obstruction, ureteral calculus, and the common condition of benign prostatic hyperplasia (BPH)."
Are there any past experiments that have tested the efficacy of Tamsulosin?
"At the current moment, 13 separate studies are underway in regards to Tamsulosin. Of these trials, 3 have progressed into Phase 3 testing. Most of them are situated around Baden and Aargau; however, a total number of 13 locations across the globe are running experiments on this drug."
To what number of participants is the research team recruiting?
"Affirmative. The records on clinicaltrials.gov indicate that this medical trial, initially published on November 3rd 2021, is in the process of sourcing participants. In total, 154 individuals are needed from 1 particular location."
Share this study with friends
Copy Link
Messenger